Latest News

Yale Cancer Center scientists have developed a novel technology that for the first time enables massively parallel DNA substitutions (known as “knock-ins”) into human cells by leveraging messenger RNA (mRNA), a platform now well-known from its use as the COVID vaccine vehicle.

The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2023 Damon Runyon-Rachleff Innovation Award, established to support “high-risk, high-reward” ideas with the potential to significantly impact the prevention, diagnosis, or treatment of cancer.

Daniel C. DiMaio, MD, PhD, was presented with the Yale Cancer Center Lifetime Achievement Award by Dr. Eric Winer at the Yale Cancer Center Conclave on January 5, 2023.

Yale researchers have made a discovery that changes conventional thinking about the role that oxygen plays in the growth of tumors—an area of cancer research that has been intensely studied in recent years.

A CAREER DEVELOPMENT GRANT FROM THE AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) HELPED YALE CANCER SCIENTIST LUISA ESCOBAR-HOYOS, MSC, PHD, EARN TWO MAJOR, MULTI-YEAR FEDERAL GRANTS TO FURTHER DEVELOP HER RESEARCH.

Giulia Biancon, PhD, has been awarded the 2022 Italian Scientists & Scholars in North America Foundation (ISSNAF) Young Investigator Paola Campese Award.

A team led by Naftali Kaminski, MD, used a newly designed molecule, called MRG-229, with potential therapeutic implications for idiopathic pulmonary fibrosis. The study is one of the first to use a microRNA mimic as a viable therapeutic in the lungs.

Two Yale faculty members, Peter M. Glazer, MD, PhD; and Saad B. Omer, MBBS, MPH, PHD; have been elected to the prestigious National Academy of Medicine, the academy announced today. Founded in 1970 as the Institute of Medicine the National Academy of Medicine (NAM) is one of three academies that make up the National Academies of Sciences, Engineering, and Medicine (the National Academies) in the United States.